New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
October 27, 2009
16:53 EDTREGN
theflyonthewall.com: Regeneron granted European marketing authorization for Rilonacept
Regeneron Pharmaceuticals announced it has received marketing authorization in the European Union for rilonacept, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes with severe symptoms, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome, in adults and children aged 12 years and older. Marketing authorization for rilonacept was granted by the Committee for Medicinal Products for Human Use of the European Medicines Agency under exceptional circumstances. :theflyonthewall.com



News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
There are 20 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 14, 2012
00:02 EDTREGN
theflyonthewall.com: Regeneron’s Eylea sales need to rise to boost the stock further, Barron's says

Subscribe for More Information
:theflyonthewall.com

February 13, 2012
16:23 EDTREGN
theflyonthewall.com: On The Fly: Closing Wrap

Subscribe for More Information
:theflyonthewall.com
12:19 EDTREGN
theflyonthewall.com: On The Fly: Mid-Day Wrap

Subscribe for More Information
:theflyonthewall.com
09:53 EDTREGN
theflyonthewall.com: Gappers report
No stocks met the criteria for bearish gaps this morning. This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING UP: DAN 6.68%, DBD 5.99%, REGN 10.25%. :theflyonthewall.com
09:48 EDTREGN
theflyonthewall.com: Regeneron target range raised to $121-$127 from $114-$120 at Leerink
Leerink raised its target range for Regeneron shares after the company raised its 2012 revenue guidance substantially. The firm keeps an Outperform rating on the stock. :theflyonthewall.com
09:25 EDTREGN
theflyonthewall.com: Pre-market top 5 gainers
The following stocks were the top percentage gainers before the open on solid volume of at least 50,000 shares, trading at over $10. REGN 11.2%, CHK 2.8%, DMND 2%, C 2%, F 2%. :theflyonthewall.com
07:14 EDTREGN
theflyonthewall.com: Regeneron, Sanofi finalizing plans for initiating Phase 3 program for REGN727
Initial data from the third Phase 2 trial, studying subcutaneous regimens of REGN727 in combination with atorvastatin in patients with primary hypercholesterolemia, will be available in 1H of 2012. :theflyonthewall.com
07:13 EDTREGN
theflyonthewall.com: Regeneron's ARCALYST PDUFA date still set for July 30

Subscribe for More Information
:theflyonthewall.com
07:12 EDTREGN
theflyonthewall.com: Regeneron to initiate Phse 3 study in BRVO in Q1 of 2012

Subscribe for More Information
:theflyonthewall.com
07:11 EDTREGN
theflyonthewall.com: Regeneron's EYLEA PDUFA date still set for September 23

Subscribe for More Information
:theflyonthewall.com
07:09 EDTREGN
theflyonthewall.com: Regeneron antibodies: sarilumab and REGN727 will be in Phase 3 testing in 2012

Subscribe for More Information
:theflyonthewall.com
07:08 EDTREGN
theflyonthewall.com: Regeneron raises 2012 EYLEA U.S. Sales forecast to $250M-$300M

Subscribe for More Information
:theflyonthewall.com
07:08 EDTREGN
theflyonthewall.com: Regeneron Q4 EYLEA net product sales $24.8M; in-line with preannouncement
:theflyonthewall.com
07:01 EDTREGN
theflyonthewall.com: Regeneron reports Q4 adjusted EPS (37c) vs. consensus (60c)

Subscribe for More Information
:theflyonthewall.com

February 9, 2012
09:53 EDTREGN
theflyonthewall.com: Regeneron management to meet with Leerink
Group dinner to be held in New York on February 16 at 6 pm hosted by Leerink. :theflyonthewall.com

February 6, 2012
10:44 EDTREGN
theflyonthewall.com: On The Fly: Analyst Downgrade Summary

Subscribe for More Information
:theflyonthewall.com
05:51 EDTREGN
theflyonthewall.com: Regeneron downgraded to Neutral from Overweight at Piper Jaffray

Subscribe for More Information
:theflyonthewall.com

February 3, 2012
10:31 EDTREGN
theflyonthewall.com: On The Fly: Analyst Initiation Summary

Subscribe for More Information
:theflyonthewall.com
06:44 EDTREGN
theflyonthewall.com: Regeneron initiated with a Buy at ThinkEquity

Subscribe for More Information
:theflyonthewall.com

January 31, 2012
08:01 EDTREGN
theflyonthewall.com: Regeneron target raised to $115 from $93 at BMO Capital

Subscribe for More Information
:theflyonthewall.com